Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HS.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HS.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HH.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HU.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HU.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HU.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HU.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GP.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
XBVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used